{"id":"W2952746195","doi":"10.1136/annrheumdis-2019-eular.8709","title":"LB0005 MULTICENTRE, RANDOMISED, OPEN-LABEL, ASSESSOR-BLINDED, PARALLEL-GROUP HEAD-TO-HEAD COMPARISON OF THE EFFICACY AND SAFETY OF IXEKIZUMAB VERSUS ADALIMUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS NAIVE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: 24-WEEK RESULTS","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Psoriatic arthritis; Ixekizumab; Adalimumab; Internal medicine; Psoriasis; Population; Clinical trial; Placebo; Physical therapy; Arthritis; Rheumatoid arthritis; Secukinumab; Immunology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005440144,0.00298081,0.005767975,0.0009182697,0.0007413342,0.00225661,0.002175633,0.003049725,0.0119595],"category_scores_gemma":[0.005190882,0.001704042,0.003914892,0.0008061416,0.002941878,0.002023365,0.001129698,0.004219485,0.00223705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001525218,"about_ca_system_score_gemma":0.002353077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003264818,"about_ca_topic_score_gemma":0.005102679,"domain_scores_codex":[0.9969958,0.001835776,0.0002353955,0.0004133199,0.0002066298,0.0003129561],"domain_scores_gemma":[0.9976951,0.0006725481,0.0005148225,0.0002929076,0.000184654,0.0006398113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9932625,0.001848254,0.00009214198,0.0001872781,0.0005143484,0.00000662745,0.00001867301,0.0001005549,0.0007875108,0.0000393875,0.0002176879,0.002925147],"study_design_scores_gemma":[0.9713033,0.02747596,0.0004883835,0.00001225155,0.0002545837,0.000005668579,0.00000821532,0.0001525147,0.00011213,0.00004476339,0.0001324235,0.000009677641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747581,0.005195663,0.002731086,0.0007856601,0.001806444,0.007354422,0.002795256,0.0006401843,0.003933056],"genre_scores_gemma":[0.9748265,0.002030424,0.004393004,0.001587974,0.001060525,0.007297265,0.002603217,0.00009802276,0.006103095],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0119595,"threshold_uncertainty_score":0.04000849,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06988501346317202,"score_gpt":0.3605372689112343,"score_spread":0.2906522554480623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}